A randomized, controlled, repeat-dose study of batefenterol/fluticasone furoate compared with placebo in the treatment of COPD
C Crim, M Gotfried, S Spangenthal, M Watkins… - BMC Pulmonary …, 2020 - Springer
… WM or maximum 0–4-h corrected QT interval, or mean HR based on … Inhaled bronchodilator
therapy with long-acting β 2 -… in a meta-analysis of data from 23,168 patients with COPD [20]. …
therapy with long-acting β 2 -… in a meta-analysis of data from 23,168 patients with COPD [20]. …
Inhaled bronchodilators for the prevention and treatment of chronic lung disease in preterm infants
G Ng, M Bruschettini, J Ibrahim… - … of Systematic Reviews, 2024 - cochranelibrary.com
… ' corrected gestational age). Future trials should be conducted to evaluate whether inhaled
… with long‐acting β 2 agonists (LABA), improves spirometry and exercise capacity in children …
… with long‐acting β 2 agonists (LABA), improves spirometry and exercise capacity in children …
Unmet diagnostic and therapeutic opportunities for chronic obstructive pulmonary disease in low-and middle-income countries
KEH Florman, T Siddharthan, SL Pollard… - American journal of …, 2023 - atsjournals.org
… symptoms, health status, and exercise capacity (19). Despite … (eg, short- and long-acting
bronchodilators) could translate to … disease (COPD) in 2019: a systematic review and modelling …
bronchodilators) could translate to … disease (COPD) in 2019: a systematic review and modelling …
Cardiovascular disease and risk in COPD: a state of the art review
… Citation55 A recent meta-analysis showed that COPD-OSA … ICS are anti-inflammatory, and
long-acting bronchodilators … with either improved exercise capacity or quality of life in COPD. …
long-acting bronchodilators … with either improved exercise capacity or quality of life in COPD. …
[HTML][HTML] Bronchoscopic lung volume reduction: who, what, where, when?
JS Kurman, DK Hogarth - Shanghai Chest, 2021 - shc.amegroups.org
… Bronchodilators include long-acting muscarinic antagonists, … emphysema and poor baseline
exercise capacity (9,10). High … A recent meta-analysis identified the following risk ratios (RRs…
exercise capacity (9,10). High … A recent meta-analysis identified the following risk ratios (RRs…
Compliance of pharmacotherapy with GOLD guidelines: a longitudinal study in patients with COPD
FA Grewe, NA Sievi, M Bradicich… - … journal of chronic …, 2020 - Taylor & Francis
… events and the superior effectiveness of long-acting bronchodilators (BD) in decreasing …
P-values were Bonferroni corrected. Categorical variables were assessed by Chi-squared …
P-values were Bonferroni corrected. Categorical variables were assessed by Chi-squared …
[HTML][HTML] Posters from the Canadian Society of Respiratory Therapists 2021 Annual Conference
EOFIFON DYSPNEA - Can J Respir Ther Vol - ncbi.nlm.nih.gov
… -LVRS, through improvements in exercise capacity, 6-min … , various systematic reviews, and
network meta analysis … would have been allocated towards correcting and compensating for …
network meta analysis … would have been allocated towards correcting and compensating for …
Addressing advance care planning in patients with COPD
EK Rose, J O'Connor - Chest, 2022 - Elsevier
… and long-acting beta agonist, a long-acting muscarinic agonist, … , obstruction, dyspnea,
exercise capacity) index is a scoring … A systematic review and meta-analysis on the effect of ACP …
exercise capacity) index is a scoring … A systematic review and meta-analysis on the effect of ACP …
COPD and cardiovascular disease: a review of association, interrelationship, and basic principles for integrated management
… Although they help improve symptoms and exercise capacity… A study has shown that use
of long-acting β-agonist and … in COPD mainly consists of smoking cessation and correction …
of long-acting β-agonist and … in COPD mainly consists of smoking cessation and correction …
[Translated article] Spanish COPD Guideline (GesEPOC) Update: Comorbidities, Self-Management and Palliative Care
JL Lopez-Campos, P Almagro, JT Gómez… - Archivos de …, 2022 - Elsevier
… to exercise tolerance needs to be determined. Furthermore, … to ensure the correct dosing of
long-acting compounds. Second, if … This clinical presentation can be corrected by weight loss. …
long-acting compounds. Second, if … This clinical presentation can be corrected by weight loss. …